Presbyterian Healthcare Services

Presbyterian Healthcare Services was paid $345.54M by Medicaid between Jan 2018 and Dec 2024, across 864 billing codes. Its largest line is 99285, emergency room visit (most serious) — 16% of everything it billed.

33Billing provider infoPRESBYTERIAN HEALTHCARE SERVICES
ALBUQUERQUE, NM 87106

33aNPI1215913470assigned 12/20/2005

33bProvider typeEmergency Medicine Physician

28Total paid$345.54M

24GClaims6,794,821

24DCodes billed864

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Emergency Medicine Physician providers in New Mexico

Rank by total paid#1 of 39

Median peer was paid$669K

This provider vs. median516×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	898,436	$48.98M
2019	877,742	$41.57M
2020	643,800	$30.54M
2021	756,127	$31.19M
2022	1,041,475	$49.77M
2023	1,420,095	$76.65M
2024incomplete	1,157,146	$66.83M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	16%	234,479	223,340	$56.35M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	258,134	245,986	$46.50M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.0%	126,913	119,346	$17.15M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.2%	36,516	35,232	$10.93M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.7%	75,575	72,613	$9.38M
90378		2.0%	2,114	2,002	$7.00M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.0%	152,850	122,296	$6.99M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.9%	80,814	76,897	$6.67M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.7%	100,521	85,049	$5.93M
70450	Computed tomography, head or brain; without contrast material	1.4%	31,364	29,838	$5.00M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.3%	10,854	10,730	$4.52M
G0378	Hospital observation service, per hour	1.3%	8,967	8,414	$4.49M

852 more codes

D2930	Prefabricated stainless steel crown - primary tooth	1.1%	24,723	$3.64M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.0%	92,938	$3.55M
99214	Doctor's office visit, returning patient (more involved)	<1%	28,026	$3.40M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	398,618	$3.03M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	62,538	$3.00M
96375	Therapeutic injection; each additional sequential IV push	<1%	61,066	$2.97M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	63,910	$2.84M
99213	Doctor's office visit, returning patient (routine)	<1%	35,996	$2.78M
71046	Radiologic examination, chest; 2 views	<1%	55,444	$2.73M
80048	Basic metabolic panel (calcium, ionized)	<1%	251,918	$2.38M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	67,995	$2.36M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	68,009	$2.34M
47562		<1%	805	$2.33M
71275	Computed tomographic angiography, chest, with contrast material	<1%	7,775	$2.20M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	4,658	$2.20M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,736	$2.10M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	45,837	$1.98M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	19,728	$1.92M
84443	Thyroid stimulating hormone (TSH)	<1%	125,867	$1.90M
80053	Comprehensive metabolic panel	<1%	186,402	$1.87M
81513		<1%	13,812	$1.73M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	8,410	$1.66M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,611	$1.65M
93976		<1%	11,308	$1.57M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	931	$1.56M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,681	$1.52M
87631		<1%	11,451	$1.49M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	15,544	$1.46M
D2934		<1%	10,173	$1.46M
96361	Intravenous infusion, hydration; each additional hour	<1%	41,339	$1.45M
90791	Psychiatric diagnostic evaluation	<1%	12,624	$1.45M
99203	Doctor's office visit, new patient (routine)	<1%	13,696	$1.39M
72125	Computed tomography, cervical spine; without contrast material	<1%	7,372	$1.38M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	49,534	$1.28M
95811		<1%	1,838	$1.23M
27447		<1%	207	$1.20M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	12,191	$1.11M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	46,023	$1.11M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	43,167	$1.10M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	11,401	$1.09M
99204	Doctor's office visit, new patient (more involved)	<1%	6,187	$1.05M
44970		<1%	346	$1.05M
71045	Radiologic examination, chest; single view	<1%	23,027	$1.02M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	13,657	$1.02M
76830	Ultrasound, transvaginal	<1%	10,670	$1.02M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,407	$993K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,216	$981K
80076		<1%	102,192	$972K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,508	$954K
84484		<1%	62,864	$943K
59025	Fetal non-stress test	<1%	8,866	$907K
83036	Hemoglobin; glycosylated (A1C)	<1%	106,429	$901K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	9,396	$816K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	28,021	$815K
D3310		<1%	6,660	$805K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,747	$801K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	23,161	$797K
73562		<1%	10,559	$774K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	5,927	$746K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,144	$744K
81514		<1%	3,922	$724K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	5,301	$721K
87481		<1%	16,796	$720K
D0220	Intraoral - periapical first radiographic image	<1%	3,158	$716K
83690		<1%	72,991	$712K
36415	Collection of venous blood by venipuncture	<1%	145,533	$709K
87086	Culture, bacterial; quantitative colony count, urine	<1%	92,689	$703K
D7140	Extraction, erupted tooth or exposed root	<1%	4,684	$692K
70496		<1%	2,454	$683K
70498		<1%	2,561	$682K
D0230	Intraoral - periapical each additional radiographic image	<1%	4,603	$643K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	4,620	$633K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	352	$631K
84439		<1%	74,590	$623K
73610		<1%	7,888	$619K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	7,114	$618K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	26,534	$615K
49083		<1%	1,828	$599K
D0272	Bitewings - two radiographic images	<1%	4,324	$596K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,529	$588K
70486		<1%	3,202	$582K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,817	$574K
73030		<1%	8,201	$568K
D1120	Dental cleaning, child	<1%	3,934	$562K
73130		<1%	9,605	$547K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,306	$545K
82075		<1%	27,870	$544K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	15,165	$533K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	52,524	$527K
82728		<1%	41,477	$525K
87650		<1%	25,266	$508K
58571		<1%	189	$507K
81025		<1%	54,030	$507K
80061	Lipid panel	<1%	42,190	$503K
52356		<1%	197	$498K
84702		<1%	28,255	$479K
64493		<1%	1,046	$466K
87505		<1%	3,210	$463K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	908	$463K
70491		<1%	1,701	$462K
85027		<1%	78,946	$459K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	30,287	$454K
D0240		<1%	2,907	$447K
76801		<1%	4,419	$442K
73630		<1%	8,469	$437K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	10,524	$435K
96376		<1%	18,169	$434K
88307		<1%	3,570	$433K
86780		<1%	32,466	$432K
72100		<1%	6,062	$426K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,037	$416K
86803		<1%	30,230	$405K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	258	$401K
74174		<1%	1,028	$397K
93971		<1%	5,901	$390K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	2,485	$387K
76536		<1%	4,446	$380K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,197	$364K
64635		<1%	464	$362K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	236	$359K
80074		<1%	8,008	$359K
76770		<1%	4,158	$353K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	10,343	$328K
73110		<1%	6,090	$324K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	13,485	$324K
99499		<1%	2,205	$323K
87077		<1%	36,907	$322K
81003		<1%	96,063	$321K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	686	$316K
97162		<1%	8,596	$313K
97113		<1%	4,350	$309K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	1,760	$302K
77385		<1%	886	$300K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,170	$296K
87653		<1%	8,506	$292K
83880		<1%	12,409	$291K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,778	$290K
83605		<1%	20,163	$287K
D1206	Topical application of fluoride varnish	<1%	3,151	$283K
76870		<1%	3,014	$282K
83550		<1%	33,810	$275K
43235		<1%	610	$269K
30140		<1%	181	$261K
72141		<1%	1,001	$258K
82607		<1%	20,002	$257K
74018		<1%	4,621	$257K
95782		<1%	299	$257K
86480		<1%	4,367	$255K
74183		<1%	603	$254K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,771	$254K
D3330	Endodontic therapy, molar tooth (excluding final restoration)	<1%	2,193	$253K
74178		<1%	1,054	$252K
87186		<1%	28,704	$250K
93970		<1%	2,400	$250K
81001		<1%	57,769	$247K
88342		<1%	5,347	$247K
72158		<1%	575	$230K
86235		<1%	2,993	$228K
12001		<1%	2,456	$225K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	807	$220K
86850		<1%	23,295	$218K
71250		<1%	1,781	$218K
73080		<1%	3,880	$211K
83540		<1%	34,526	$206K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	34,721	$203K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	5,945	$203K
86923		<1%	1,400	$202K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	1,767	$201K
64636		<1%	816	$199K
83970		<1%	5,831	$198K
72040		<1%	2,712	$198K
64490		<1%	449	$193K
83516		<1%	8,954	$192K
J0897	Injection, denosumab, 1 mg	<1%	523	$191K
87040		<1%	10,025	$190K
84703		<1%	20,745	$189K
87340		<1%	19,037	$189K
36430		<1%	1,028	$188K
47563		<1%	75	$185K
95813		<1%	990	$185K
72131		<1%	1,181	$184K
87522	Neg quan hep c or qual rna	<1%	4,406	$184K
82746		<1%	14,377	$181K
70487		<1%	591	$175K
29125		<1%	1,607	$174K
71101		<1%	2,444	$172K
82962		<1%	35,118	$172K
86140		<1%	38,515	$169K
99222	Initial hospital care, per day, moderate complexity	<1%	1,204	$167K
83735		<1%	25,971	$165K
77301		<1%	252	$162K
84403		<1%	6,520	$161K
72070		<1%	2,226	$160K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,155	$156K
77386		<1%	430	$156K
95819		<1%	1,055	$156K
73502		<1%	4,184	$155K
73090		<1%	2,714	$154K
86762		<1%	10,907	$153K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	73	$153K
10005		<1%	266	$151K
73590		<1%	2,917	$150K
10060		<1%	1,849	$150K
73221		<1%	521	$150K
J1750	Injection, iron dextran, 50 mg	<1%	624	$148K
84112		<1%	1,856	$148K
85379		<1%	12,897	$146K
86038		<1%	12,767	$144K
12011		<1%	1,444	$140K
82805		<1%	3,335	$139K
96367		<1%	3,434	$139K
78264		<1%	601	$139K
58661		<1%	51	$138K
87902		<1%	537	$138K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	240	$138K
85610		<1%	36,811	$138K
74019		<1%	1,380	$136K
87660		<1%	7,018	$136K
82570		<1%	30,373	$136K
87510		<1%	7,004	$136K
87480		<1%	7,017	$135K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	832	$135K
20610		<1%	1,819	$134K
86787		<1%	10,578	$133K
J3490	Unclassified drugs	<1%	129,865	$131K
12002		<1%	1,487	$130K
88185		<1%	548	$130K
73700		<1%	769	$128K
74022		<1%	1,479	$127K
82784		<1%	12,866	$126K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	321	$124K
43249		<1%	353	$119K
77336		<1%	1,532	$116K
86900		<1%	25,383	$114K
D2330		<1%	933	$112K
0225U		<1%	288	$110K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,232	$110K
82043		<1%	22,023	$108K
36000		<1%	17,718	$107K
82077		<1%	9,431	$107K
97163		<1%	1,892	$105K
78227		<1%	397	$104K
87632		<1%	470	$103K
80047		<1%	9,375	$103K
84153		<1%	6,434	$103K
93017		<1%	830	$103K
D1351	Sealant - per tooth	<1%	888	$103K
85652		<1%	33,452	$100K
86160		<1%	4,754	$98K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,275	$98K
83001		<1%	5,188	$96K
D2331		<1%	823	$95K
82670		<1%	3,323	$93K
84270		<1%	4,398	$92K
29581		<1%	1,304	$90K
90715		<1%	5,997	$89K
88341		<1%	747	$88K
86901		<1%	25,308	$88K
97597		<1%	1,300	$86K
73701		<1%	302	$86K
86376		<1%	5,973	$84K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,087	$80K
64494		<1%	1,033	$80K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,181	$80K
30520		<1%	78	$79K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	685	$78K
J0248	Injection, remdesivir, 1 mg	<1%	221	$78K
97161		<1%	3,591	$77K
87075		<1%	6,210	$77K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	779	$77K
88304		<1%	3,429	$76K
64495		<1%	984	$75K
87070		<1%	8,063	$75K
94010		<1%	677	$74K
84146		<1%	3,775	$74K
86706		<1%	7,174	$73K
86704		<1%	6,463	$73K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	3,411	$73K
96415		<1%	1,617	$73K
87081		<1%	11,846	$71K
82378		<1%	4,427	$71K
83002		<1%	3,811	$70K
93797		<1%	2,041	$69K
76775		<1%	854	$69K
82565		<1%	14,243	$69K
84425		<1%	3,488	$67K
84481		<1%	4,066	$66K
87338		<1%	4,808	$65K
73140		<1%	1,209	$65K
82274		<1%	4,505	$63K
62323		<1%	175	$62K
86147		<1%	1,152	$62K
85730		<1%	10,774	$61K
Q3014	Telehealth originating site facility fee	<1%	3,924	$61K
83655		<1%	4,683	$61K
86200		<1%	4,811	$59K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	43,587	$58K
72156		<1%	131	$58K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	944	$58K
94375		<1%	910	$58K
51702		<1%	1,468	$57K
77300		<1%	326	$56K
73522		<1%	1,015	$56K
87529		<1%	1,531	$56K
82550		<1%	9,152	$55K
73060		<1%	1,097	$55K
77014		<1%	1,878	$55K
64721		<1%	56	$55K
82248		<1%	11,060	$55K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	110	$55K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	299	$54K
74240		<1%	619	$54K
86258		<1%	4,966	$53K
77338		<1%	261	$53K
82024		<1%	1,404	$53K
86146		<1%	1,019	$53K
84305		<1%	1,901	$53K
97166		<1%	1,555	$52K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	107	$52K
86431		<1%	9,803	$52K
83615		<1%	9,050	$51K
86364		<1%	4,948	$51K
74230		<1%	676	$50K
51701		<1%	626	$50K
77334		<1%	181	$50K
77427		<1%	421	$50K
82951		<1%	3,802	$49K
82247		<1%	9,496	$48K
86800		<1%	3,132	$48K
36561		<1%	42	$48K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	183	$47K
D1510		<1%	416	$47K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	42,812	$47K
92611		<1%	653	$46K
86225		<1%	3,377	$46K
83993		<1%	2,416	$46K
36591		<1%	1,219	$46K
82105		<1%	3,051	$45K
82533		<1%	2,693	$45K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	962	$45K
86870		<1%	253	$45K
82803		<1%	1,780	$44K
84100		<1%	9,687	$44K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	12,025	$44K
29515		<1%	643	$43K
84550		<1%	10,033	$43K
72110		<1%	658	$43K
70360		<1%	763	$43K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	2,920	$42K
90837	Psychotherapy session, about an hour	<1%	983	$42K
86003		<1%	599	$41K
88173		<1%	707	$41K
73552		<1%	948	$40K
81002		<1%	13,584	$40K
86696		<1%	2,066	$40K
D2332		<1%	339	$38K
88313		<1%	413	$38K
72197		<1%	82	$37K
76882		<1%	420	$37K
99221		<1%	353	$36K
84520		<1%	9,353	$35K
82140		<1%	2,837	$35K
86708		<1%	2,881	$34K
84132		<1%	7,962	$34K
74181		<1%	118	$34K
87205		<1%	8,076	$34K
72170		<1%	536	$33K
84460		<1%	6,457	$33K
82977		<1%	4,620	$33K
64491		<1%	446	$32K
64492		<1%	438	$32K
74220		<1%	449	$31K
86300		<1%	1,349	$31K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	5,553	$31K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	40,759	$31K
84450		<1%	6,169	$31K
77412		<1%	283	$31K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	100	$31K
84145		<1%	1,916	$30K
80143		<1%	2,119	$30K
72114		<1%	554	$29K
52332		<1%	14	$29K
82330		<1%	2,612	$29K
84295		<1%	6,214	$29K
80179		<1%	2,049	$29K
88184		<1%	550	$29K
84156		<1%	8,349	$28K
82435		<1%	6,063	$28K
83525		<1%	2,394	$28K
82947		<1%	6,707	$28K
87210		<1%	4,775	$28K
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	1,424	$27K
86255		<1%	1,482	$27K
85060		<1%	1,233	$27K
C1769	Guide wire	<1%	2,884	$27K
94060		<1%	341	$27K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	59	$27K
10022		<1%	88	$27K
86695		<1%	2,030	$27K
82731		<1%	389	$27K
83498		<1%	963	$27K
82950		<1%	5,525	$26K
95812		<1%	161	$26K
95816		<1%	203	$26K
83521		<1%	1,178	$26K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	1,460	$26K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	412	$26K
97165		<1%	1,203	$26K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	1,876	$25K
83520		<1%	1,035	$25K
84165		<1%	2,736	$25K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	118	$25K
84144		<1%	1,196	$25K
87581		<1%	707	$25K
86039		<1%	2,312	$25K
74420		<1%	191	$25K
28285		<1%	36	$24K
87799		<1%	631	$24K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	38	$24K
51798		<1%	1,029	$24K
87486		<1%	694	$24K
97016		<1%	2,035	$24K
97802		<1%	596	$24K
99195		<1%	394	$24K
84480		<1%	1,742	$23K
86304		<1%	1,179	$23K
86381		<1%	1,023	$23K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	43,513	$22K
58563		<1%	12	$22K
82040		<1%	4,501	$22K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	19,407	$22K
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	<1%	3,719	$22K
82103		<1%	1,654	$22K
90834	Psychotherapy session, about 45 minutes	<1%	612	$21K
97116		<1%	1,518	$21K
72128		<1%	137	$21K
90792	Psychiatric diagnostic evaluation with medical services	<1%	156	$21K
72157		<1%	45	$21K
88312		<1%	282	$20K
73120		<1%	317	$20K
64633		<1%	60	$19K
87449		<1%	1,883	$19K
41899	Unlisted procedure, dentoalveolar structures	<1%	165	$19K
78262		<1%	60	$19K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	3,670	$18K
99215	Doctor's office visit, returning patient (complex)	<1%	162	$18K
82390		<1%	1,735	$18K
93458		<1%	23	$18K
73564		<1%	423	$18K
92610		<1%	419	$18K
94625		<1%	573	$18K
97167		<1%	227	$18K
43244		<1%	42	$17K
12013		<1%	203	$17K
82627		<1%	784	$17K
76857		<1%	285	$17K
85018		<1%	5,721	$17K
J0690	Injection, cefazolin sodium, 500 mg	<1%	10,482	$17K
58558		<1%	12	$17K
82010		<1%	2,273	$16K
64483		<1%	39	$16K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	773	$16K
84207		<1%	600	$16K
86665		<1%	464	$16K
83883		<1%	1,193	$16K
85046		<1%	3,290	$16K
91299		<1%	113	$16K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	18,096	$15K
72192		<1%	139	$15K
84154		<1%	995	$15K
99152		<1%	1,815	$15K
88112		<1%	544	$14K
73000		<1%	246	$14K
84445		<1%	283	$14K
92526		<1%	272	$14K
76885		<1%	117	$13K
D2932		<1%	118	$13K
82150		<1%	2,134	$13K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	370	$13K
47000		<1%	24	$13K
86334		<1%	726	$13K
73201		<1%	40	$13K
83721		<1%	1,370	$13K
90461		<1%	489	$13K
72052		<1%	243	$13K
85014		<1%	4,725	$13K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26,319	$13K
29130		<1%	265	$13K
80164		<1%	967	$13K
84432		<1%	831	$12K
97535	Self-care/home management training, each 15 minutes	<1%	643	$12K
77072		<1%	120	$12K
86015		<1%	1,202	$12K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	432	$12K
86256		<1%	1,042	$12K
84681		<1%	578	$12K
86694		<1%	799	$12K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	630	$11K
70481		<1%	40	$11K
78306		<1%	59	$11K
J2704	Injection, propofol, 10 mg	<1%	19,488	$11K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	1,505	$11K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	208	$11K
72081		<1%	146	$11K
94726		<1%	184	$11K
82397		<1%	786	$11K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	126	$11K
D1208	Topical application of fluoride, excluding varnish	<1%	83	$11K
87634		<1%	168	$11K
85613		<1%	1,035	$10K
64634		<1%	62	$10K
93296		<1%	882	$9K
G0239	Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)	<1%	461	$9K
86308		<1%	1,389	$9K
80177		<1%	799	$9K
64615		<1%	123	$9K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	658	$9K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	3,731	$9K
96401		<1%	376	$9K
82985		<1%	632	$9K
C1776	Joint device (implantable)	<1%	543	$9K
62270		<1%	44	$9K
J2785	Injection, regadenoson, 0.1 mg	<1%	126	$8K
73560		<1%	235	$8K
D2390		<1%	77	$8K
97035		<1%	689	$8K
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	1,607	$8K
87324		<1%	676	$8K
10061		<1%	75	$8K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,266	$8K
72146		<1%	30	$8K
87328		<1%	608	$8K
73200		<1%	47	$7K
J1790	Injection, droperidol, up to 5 mg	<1%	3,003	$7K
94729		<1%	238	$7K
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	659	$7K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	313	$7K
90670		<1%	712	$7K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,509	$7K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,905	$7K
86301		<1%	415	$7K
77263		<1%	62	$7K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	10,221	$7K
94644		<1%	71	$7K
72220		<1%	144	$7K
J2060	Injection, lorazepam, 2 mg	<1%	5,921	$7K
90832	Psychotherapy session, about 30 minutes	<1%	210	$7K
89051		<1%	1,017	$6K
52000		<1%	39	$6K
86664		<1%	400	$6K
80197		<1%	888	$6K
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,926	$6K
82653		<1%	308	$6K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	14,143	$6K
74450		<1%	36	$5K
86663		<1%	400	$5K
90686		<1%	1,112	$5K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,721	$5K
90732		<1%	218	$5K
97760		<1%	129	$5K
72193		<1%	13	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	784	$5K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,358	$5K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,401	$5K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	15	$5K
73100		<1%	101	$5K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	98	$5K
82525		<1%	413	$5K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,776	$5K
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	<1%	538	$5K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	13	$5K
80178		<1%	640	$5K
74241		<1%	59	$5K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	69	$5K
J1815	Injection, insulin, per 5 units	<1%	5,691	$4K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	312	$4K
99153	Mod sedat endo service >5yrs	<1%	1,165	$4K
62321		<1%	13	$4K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	13	$4K
73620		<1%	106	$4K
87506		<1%	18	$4K
45381		<1%	13	$4K
J1644	Injection, heparin sodium, per 1000 units	<1%	4,387	$4K
97012		<1%	298	$4K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,933	$4K
82952		<1%	1,025	$4K
75574		<1%	13	$4K
76380		<1%	79	$4K
96368		<1%	287	$4K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,739	$4K
87088		<1%	609	$4K
93798		<1%	115	$4K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,289	$4K
C1781	Mesh (implantable)	<1%	501	$4K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	311	$4K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	17	$4K
77470		<1%	13	$4K
29105		<1%	56	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,079	$4K
96417		<1%	92	$3K
64450		<1%	14	$3K
76098		<1%	12	$3K
88300		<1%	292	$3K
86060		<1%	449	$3K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	41	$3K
85246		<1%	122	$3K
69209		<1%	108	$3K
83921		<1%	167	$3K
86593		<1%	663	$3K
85245		<1%	118	$3K
84436		<1%	431	$3K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	4,916	$3K
97018		<1%	563	$3K
85045		<1%	621	$3K
73600		<1%	39	$3K
D3320		<1%	24	$3K
94681		<1%	30	$3K
A9517	Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie	<1%	12	$3K
T1017	Case management, billed per 15 minutes	<1%	12	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,300	$3K
93990		<1%	74	$3K
76080		<1%	18	$3K
80069		<1%	418	$3K
82310		<1%	532	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	429	$2K
82785		<1%	140	$2K
87147		<1%	454	$2K
87015		<1%	329	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	245	$2K
86036		<1%	229	$2K
71111		<1%	25	$2K
84134		<1%	146	$2K
G0008	Administration of influenza virus vaccine	<1%	1,768	$2K
93325		<1%	354	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,058	$2K
85390		<1%	123	$2K
84238		<1%	49	$2K
88302		<1%	92	$2K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	833	$2K
88344		<1%	14	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,437	$2K
84155		<1%	586	$2K
93880		<1%	40	$2K
91320		<1%	194	$2K
71100		<1%	40	$2K
36416		<1%	782	$2K
70480		<1%	13	$2K
C1726	Catheter, balloon dilatation, non-vascular	<1%	377	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,529	$2K
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	1,262	$2K
80175		<1%	144	$2K
85240		<1%	83	$2K
A6253	Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	1,454	$2K
76942		<1%	258	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,771	$2K
C1729	Catheter, drainage	<1%	2,054	$2K
88311		<1%	285	$2K
80185		<1%	117	$2K
87209		<1%	97	$2K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	54	$2K
73660		<1%	36	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	500	$2K
95992		<1%	17	$1K
82365		<1%	132	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	709	$1K
S0028	Injection, famotidine, 20 mg	<1%	1,049	$1K
82668		<1%	84	$1K
99232	Hospital visit by a doctor, follow-up day	<1%	18	$1K
J2359	Injection, olanzapine, 0.5 mg	<1%	82	$1K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	537	$1K
64447		<1%	13	$1K
81050		<1%	388	$1K
J0475	Injection, baclofen, 10 mg	<1%	154	$1K
76937		<1%	293	$1K
99157		<1%	308	$1K
J3360	Injection, diazepam, up to 5 mg	<1%	134	$1K
84157		<1%	239	$1K
82157		<1%	41	$1K
85384		<1%	124	$1K
91065		<1%	12	$1K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	732	$1K
80050	General health panel	<1%	51	$1K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	342	$1K
82375		<1%	67	$1K
90656		<1%	243	$1K
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,604	$990.96
J1756	Injection, iron sucrose, 1 mg	<1%	201	$973.27
82652		<1%	29	$938.16
87102		<1%	119	$907.66
87177		<1%	96	$860.14
17250		<1%	165	$830.94
97168		<1%	15	$825.16
85347		<1%	81	$819.45
70160		<1%	12	$805.82
86341		<1%	27	$798.78
93320		<1%	75	$794.00
86765		<1%	61	$770.59
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	756	$760.04
A6206	Contact layer, sterile, 16 sq. in. or less, each dressing	<1%	110	$759.75
86735		<1%	58	$753.00
85130		<1%	67	$740.05
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	522	$738.50
72050		<1%	12	$736.50
S9083	Global fee urgent care centers	<1%	53,854	$725.07
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	191	$713.03
30901		<1%	13	$700.64
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	822	$692.86
73070		<1%	13	$687.08
76010		<1%	13	$682.40
J1940	Injection, furosemide, up to 20 mg	<1%	1,072	$664.41
87329		<1%	53	$654.24
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	674	$652.02
A6261	Wound filler, gel/paste, per fluid ounce, not otherwise specified	<1%	406	$649.65
82088		<1%	15	$639.12
G0009	Administration of pneumococcal vaccine	<1%	548	$637.11
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,450	$616.88
93926		<1%	12	$616.05
82945		<1%	125	$615.97
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,127	$593.44
J3489	Injection, zoledronic acid, 1 mg	<1%	37	$581.30
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	92	$567.91
80321		<1%	381	$564.50
J1836	Injection, metronidazole, 10 mg	<1%	808	$559.01
84080		<1%	41	$558.68
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	61	$520.22
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	12	$513.52
87641		<1%	12	$509.06
A6211	Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	14	$501.90
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	368	$487.09
83020		<1%	34	$486.75
86769		<1%	13	$479.43
84075		<1%	93	$468.95
84478		<1%	96	$464.13
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	828	$452.63
G0452	Molecular pathology procedure; physician interpretation and report	<1%	33	$446.21
80361		<1%	930	$446.06
94760		<1%	47	$437.75
90480		<1%	194	$434.88
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	302	$425.74
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	221	$417.25
S9443	Lactation classes, non-physician provider, per session	<1%	125	$415.00
82104		<1%	26	$391.51
82085		<1%	40	$386.04
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	265	$384.52
A6262	Wound filler, dry form, per gram, not otherwise specified	<1%	448	$379.30
84466		<1%	28	$373.97
90785		<1%	238	$348.56
84244		<1%	15	$344.97
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	902	$327.85
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,221	$318.54
82657		<1%	16	$302.04
80325		<1%	141	$294.19
A6260	Wound cleansers, any type, any size	<1%	298	$278.24
93246		<1%	12	$277.97
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	116	$275.81
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	185	$272.65
93242		<1%	13	$272.61
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	57	$268.83
87176		<1%	89	$266.26
97039		<1%	20	$265.08
69210		<1%	12	$258.13
0141U		<1%	121	$251.61
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	559	$250.52
80365		<1%	935	$249.70
94761		<1%	74	$233.09
90651		<1%	29	$224.74
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	32	$222.20
80356		<1%	952	$220.49
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	410	$213.12
82175		<1%	13	$211.57
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	188	$211.39
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	687	$197.63
84376		<1%	32	$188.76
83825		<1%	13	$188.58
83835		<1%	13	$164.94
80165		<1%	12	$162.10
99406		<1%	146	$155.34
84630		<1%	13	$153.56
89060		<1%	27	$144.24
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	107	$141.38
86709		<1%	12	$141.20
J7510	Prednisolone oral, per 5 mg	<1%	40	$139.16
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	157	$134.03
74300		<1%	29	$125.05
C1758	Catheter, ureteral	<1%	178	$121.35
82705		<1%	25	$121.09
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	107	$120.63
87184		<1%	15	$105.12
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	295	$104.91
89050		<1%	29	$104.42
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	82	$103.15
49424		<1%	18	$99.24
Q2039	Influenza virus vaccine, not otherwise specified	<1%	220	$97.57
99151		<1%	39	$90.58
90756		<1%	18	$74.43
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	310	$74.14
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	33	$72.73
83930		<1%	12	$70.48
82465		<1%	17	$68.24
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	<1%	152	$65.58
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	780	$63.50
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	293	$62.36
J0736	Injection, clindamycin phosphate, 300 mg	<1%	34	$59.06
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	46	$56.55
C1788	Port, indwelling (implantable)	<1%	40	$51.23
0001A		<1%	327	$50.39
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	83	$48.70
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	430	$47.19
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	186	$46.68
81015		<1%	16	$44.77
90677		<1%	124	$41.05
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	64	$40.62
0124A		<1%	45	$40.10
J0456	Injection, azithromycin, 500 mg	<1%	56	$37.72
99155		<1%	15	$32.01
J2805	Injection, sincalide, 5 micrograms	<1%	38	$30.53
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	339	$26.29
51610		<1%	24	$25.55
A4452	Tape, waterproof, per 18 square inches	<1%	645	$18.66
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	129	$14.31
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	73	$13.54
C2625	Stent, non-coronary, temporary, with delivery system	<1%	14	$8.66
77001		<1%	118	$4.67
96377		<1%	17	$3.45
90662		<1%	104	$1.01
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	120	$0.01
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	119	$0.01
90633		0%	12	$0.00
0002A		0%	263	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	112	$0.00
80346		0%	52	$0.00
97799		0%	20	$0.00
A9153	Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified	0%	19	$0.00
37253		0%	15	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	13	$0.00
75774		0%	13	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	90	$0.00
A4649	Surgical supply; miscellaneous	0%	47	$0.00
D3230		0%	466	$0.00
37252		0%	15	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	19	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	198	$0.00
0031A		0%	36	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	247	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	17	$0.00
90688		0%	27	$0.00
D3240		0%	77	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	44	$0.00
0011A		0%	59	$0.00
0134A		0%	18	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	14	$0.00
0012A		0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPOLAND, KIMBERLY (MANAGER)

Same official

Other billing entities under POLAND, KIMBERLY

Full network →

Provider	Location	Paid
Presbyterian Healthcare Services	Santa Fe, NM	$21.55M
Presbyterian Healthcare Services	Santa Fe, NM	$292K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.